Skip to content

Clinical trials

RNA Virus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: RNA Virus Infections Country / region: United States Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20121
20135
20145
20151
20164
20174
20183
20191
202010
20217
20223
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Recruiting5
Terminated5
Active, not recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)14
Gilead Sciences6
Medicago6
BioNTech SE2
Emergent BioSolutions2
Pfizer2
University of California, Los Angeles2
Adrian Hernandez1
Ambry Genetics1
Arbutus Biopharma Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
RNA Virus Infections52
Virus Diseases46
COVID-1922
Coronavirus Infections22
Coronaviridae Infections19
Nidovirales Infections18
Respiratory Tract Infections17
Respiratory Tract Diseases16
Infections15
Severe Acute Respiratory Syndrome13

Trials

Showing 26 to 50 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.